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Abstract
Background: During pregnancy, malaria infection with Plasmodium falciparum or Plasmodium vivax is related to
adverse maternal health and poor birth outcomes. Diagnosis of malaria, during pregnancy, is complicated by the
absence or low parasite densities in peripheral blood. Diagnostic methods, other than microscopy, are needed for
detection of placental malaria. Therefore, the diagnostic accuracy of rapid diagnostic tests (RDTs), detecting
antigen, and molecular techniques (PCR), detecting DNA, for the diagnosis of Plasmodium infections in pregnancy
was systematically reviewed.
Methods: MEDLINE, EMBASE and Web of Science were searched for studies assessing the diagnostic accuracy of
RDTs, PCR, microscopy of peripheral and placental blood and placental histology for the detection of malaria
infection (all species) in pregnant women.
Results: The results of 49 studies were analysed in metandi (Stata), of which the majority described P. falciparum
infections. Although both placental and peripheral blood microscopy cannot reliably replace histology as a
reference standard for placental P. falciparum infection, many studies compared RDTs and PCR to these tests. The
proportion of microscopy positives in placental blood (sensitivity) detected by peripheral blood microscopy, RDTs
and PCR are respectively 72% [95% CI 62-80], 81% [95% CI 55-93] and 94% [95% CI 86-98]. The proportion of
placental blood microscopy negative women that were negative in peripheral blood microscopy, RDTs and PCR
(specificity) are 98% [95% CI 95-99], 94% [95% CI 76-99] and 77% [95% CI 71-82]. Based on the current data, it was
not possible to determine if the false positives in RDTs and PCR are caused by sequestered parasites in the
placenta that are not detected by placental microscopy.
Conclusion: The findings suggest that RDTs and PCR may have good performance characteristics to serve as
alternatives for the diagnosis of malaria in pregnancy, besides any other limitations and practical considerations
concerning the use of these tests. Nevertheless, more studies with placental histology as reference test are urgently
required to reliably determine the accuracy of RDTs and PCR for the diagnosis of placental malaria. P. vivax-
infections have been neglected in diagnostic test accuracy studies of malaria in pregnancy.
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Malaria infection during pregnancy is a major public
health problem in subtropical regions throughout the
world. An estimated 125.2 million pregnancies occurred
in areas with Plasmodium falciparum and/or Plasmo-
dium vivax transmission in 2007, of which approxi-
mately 30.3 million occurred in Africa [1,2]. Of the five
human malaria species, P. falciparum causes the most
severe effects during pregnancy, and P. vivax is asso-
ciated with maternal anaemia and low birth weight [3,4].
The effects of Plasmodium malariae, Plasmodium ovale
and Plasmodium knowlesi infections in pregnancy are
not well studied. P. falciparum infection during preg-
nancy is estimated to cause 10,000 maternal deaths each
year and annually an estimated 75,000-200,000 infant
deaths are linked to malaria in pregnancy (MiP)
[1,2,5,6]. In low-transmission areas, P. falciparum infec-
tion during pregnancy usually presents as a sympto-
matic, severe disease that can result in death of mother
and foetus. In high-transmission areas few P. falciparum
infections result in fever and maternal death, but the
newborn infant can be severely affected by intrauterine
growth retardation and pre-term delivery [2]. Infants
born after a pregnancy affected by malaria often suffer
from anaemia and have an increased risk of contracting
malaria themselves [2]. Furthermore, P. falciparum
infection during pregnancy increases the risk of stillbirth
[2]. The severe effects of P. falciparum and P. vivax
malaria on pregnant women and their (unborn) infants
make early detection and subsequent treatment of great
importance. Even though there are control measures to
prevent malaria infection during pregnancy, such as
intermittent preventive treatment (IPTp) and bed nets
(ITNs), diagnosis is essential in areas where there is
anti-malarial or insecticide resistance. IPTp greatly
reduces prevalence of malaria and severe consequences,
but women are not protected throughout the entire
pregnancy and can still become infected between doses
or after the final dose, especially when other protective
measures such as ITNs are not being used, or parasites
are resistant to sulphadoxine-pyrimethamine. IPTp is
mostly applied in areas where there is high malaria
transmission, where women have acquired immunity
and infection during the pregnancy is often asympto-
matic, but not without consequences. Therefore, accu-
rate diagnostic tools are necessary to confirm infection.
Additionally, screening and subsequent treatment of
women during pregnancy might be more effective than
a preventive approach in areas with low levels of trans-
mission or highly seasonal transmission [7,8]. Using
IPTp in low transmission areas might result in a large
proportion of pregnant women receiving sulphadoxine-
pyrimethamine unnecessarily and a strategy has been
proposed to screen pregnant women at antenatal care
(ANC) visits with a rapid diagnostic test (RDT) and
treat women who are positive with an effective anti-
malarial [8]. An essential element of this strategy is
good accuracy of the test and moreover it requires an
affordable and quick diagnostic tool, such as an RDT.
P. falciparum infection in pregnant women presents
differently than in non-pregnant women, where parasites
are found in the circulation and can sequester to
endothelial cells [9]. In pregnant women, P. falciparum
malaria parasites express a different antigen variant
( V A R 2 C S A )t h a ni nn o n - p r e g n a n tw o m e n ,a l l o w i n g
them to sequester in the placenta and this is known as
placental malaria [10]. Hence, in pregnant women per-
ipheral parasitaemia can be absent or below the detec-
tion limit of microscopy [11,12].
While microscopic examination of blood slides is con-
sidered the ‘gold standard’ for diagnosis in non-preg-
nancy related malaria, accurate detection of parasite
infection in the placenta requires examination of histo-
logical sections of fixed placental tissue [13-15]. An
alternative is to examine placental blood with micro-
scopy [11,12,15]. Placental histology and microscopic
examination of placental blood can only be performed
after delivery, when the placenta is available for exami-
nation. Since the detection of malaria parasites in the
placenta is not possible during pregnancy, there is at
this moment no other alternative than to detect the
infection in peripheral blood.
There are alternatives to microscopic examination to
test the peripheral blood though, such as rapid diagnos-
tic tests (RDTs), which have the advantage of being
quick and easy in remote settings. Depending on the
manufacturer, the quality of the RDT in terms of accu-
racy and stability can be high [16,17]. RDTs are based
on the detection of parasite antigens in the blood by
specific monoclonal antibodies. RDTs for malaria detect
one or more of the following antigens: Histidine Rich
Protein 2 (HRP2), Plasmodium Lactate Dehydrogenase
(pLDH) or Aldolase. In a recent systematic review com-
paring diagnostic accuracy of RDTs for uncomplicated
P. falciparum infection, it was reported that HRP2-
based RDTs have better sensitivity than pLDH-based
tests, although specificity is better for pLDH-based tests
[18]. In general, RDTs detecting HRP2 are most com-
monly used, because they are less expensive, more stable
across a wider temperature range and have a lower
detection threshold than pLDH-based tests [19,20].
HRP2-based tests, however, detect only P. falciparum,
and antigenic variation of this antigen may cause false
negative results [21]. The HRP2 antigen is excreted
from the infected red blood cell, which can be beneficial
for the diagnosis of placental malaria, as the antigen can
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sequestered in the placenta [22].
Other alternatives for malaria diagnosis are DNA/
RNA-based detection techniques, of which the polymer-
ase chain reaction (PCR) is the most widely used
[23,24]. PCR is considered to have the most sensitive
detection level of parasites (for both regular peripheral
malaria and placental malaria), but requires highly
trained staff and specialized equipment, which are not
always available in resource-poor settings [11,12,15].
Both PCR and RDTs are reported to have a higher
sensitivity for placental malaria in peripheral and pla-
cental blood than microscopy, but are considered not to
be as accurate as placental histopathology, however, evi-
dence for this conclusion has not been summarized
[11]. Besides accuracy there are many other reasons for
choosing to use a certain type of diagnostic test, such as
affordability, number of tests to be performed in a cer-
tain time, equipment, trained staff, etc., that depend on
the setting and location in which the test will be used.
Without a sufficient level of accuracy, however, there is
no justification of using a certain test, even if it is prac-
tical and affordable and perhaps the only possibility in a
certain situation. Therefore, the aim of the present
study is to investigate the published diagnostic accuracy
of RDTs and PCR for the diagnosis of malaria infection
in pregnant women compared to a reference standard.
These tests should at least have a better sensitivity and
specificity than peripheral microscopy. Different conse-
quences of the results will be discussed.
Methods
Eligible studies
Eligible studies were primary studies that assessed the
diagnostic accuracy of RDTs, PCR, and microscopy of
peripheral- or placental blood or placental histology for
the detection of malaria in pregnant women. Studies
included pregnant women (any age, gestation and parity)
in malaria endemic regions (all human-infecting Plasmo-
dium species). Studies that compared selected healthy
controls to confirmed malaria patients (case-control)
were not eligible for inclusion, because they tend to give
an over-estimation of the sensitivity and specificity of
the test under evaluation [25]. RDTs detecting any type
of antigen (HRP2, pLDH, Aldolase), in any format (lat-
eral flow cassette, dipstick, card etc.) and from any man-
ufacturer were eligible as well as molecular diagnostic
tests (PCR) in any format using Plasmodium DNA and/
or RNA amplification.
Definitions
Malaria infection of red blood cells in pregnant women
can be found in both the peripheral and placental circu-
lation and sequestered in the placenta and other organs
or tissue. Placental malaria is defined as the presence of
malaria parasites in placental tissue or blood in this
study. Peripheral malaria infection is defined as the pre-
sence of malaria parasites in the circulation (peripheral
blood). Both types of infection often occur at the same
time and when it is not clear which of the two it is or
specification is not desired, it is called malaria in preg-
nancy (MiP).
Reference test: histology
Histological examination of a stained biopsy from the
maternal side of the placenta is considered the gold
standard for diagnosis of placental malaria. The biopsy
is examined for the presence of malaria parasites and
pigment in the placental tissue. Placental histology slides
can be classified in active (parasites in the placenta),
active chronic (parasites and pigment in placenta), past
(only pigment in placenta) and no infection (no para-
sites or pigment in placenta) [13,14]. For the 2 × 2
tables both active and active-chronic infections were
considered as positive for placental malaria and past and
no infections as negative. Even though past infection is
a clinically relevant outcome, and indicates that the par-
ticipant has been infected during the pregnancy, for the
purpose of comparing diagnostics only the current state
of infection is of interest. In one study, past infection
was considered as positive and the results were not pre-
sented for each class separately [26]. This study was not
included in the meta-analysis, because it was the only
study comparing RDT to histology. In two other studies,
it was not specified if past infection was considered
positive or negative. These studies were included in the
meta-analysis and may be a source of bias [27,28].
Reference tests: placental and peripheral blood
microscopy
Histology is not available or practical in all situations,
and not suitable for certain study designs. Instead,
microscopic slide investigation of placental or peripheral
blood is used as reference test. Slides are made from
placental blood from the inter-villous space of the pla-
centa, which can be collected in many different ways,
for example, by aspiration with a syringe or as impres-
sion smear of placental tissue. For peripheral blood
microscopy, venous or capillary blood is collected and
thick and thin smears are made. Slides from blood of
both sources are dried, fixed (thin smear), stained and
examined microscopically for the presence of malaria
parasites. Although peripheral parasitaemia during preg-
nancy has been related to placental infection at delivery,
microscopy of peripheral blood indicates a different
situation than histology; i.e. it detects parasites in the
circulation (with or without placental infection) [29]. In
order to gain more insight into the value of these
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against placental histology.
Search strategy
Electronic databases were searched with the provided
search terms. To avoid missing studies, the search terms
were kept broad. The searches were performed in Sep-
tember 2009 in duplicate and updated in October 2010
and June 2011.
Medline (through Pubmed) was searched with ("malar-
ia"[MeSH Terms] OR Plasmodium [All Fields] OR
“malaria"[All Fields]) AND ("pregnancy"[MeSH Terms]
OR “pregnancy"[All Fields] OR pregnan*[ti]).
EMBASE (through OVID) was searched with search
terms: (’malaria’/exp or ‘malaria’.mp. or (’plasmodium’/
exp or ‘plasmo*’.mp.)) and (’pregnancy’/exp or ‘preg-
nan*’.mp.) and ‘paludisme’.
In Web of Science the following search term was used:
TS = ((malaria OR plasmo*) AND pregnan*).
The WHO library database (through e-library OPAC
on WHO website) was searched with three terms
‘malaria AND pregnancy’, ‘paludisme AND enceinte’
and ‘paludisme AND grossesse’.
Reference lists of the selected studies, narrative and
systematic reviews and primary studies on malaria in
p r e g n a n c yw e r em a n u a l l yc h e c k e df o ro t h e rr e l e v a n t
studies. Conference programmes and abstracts of recent
conferences on malaria were consulted for recently con-
ducted studies and the websites of the Roll Back Malaria
programme, WHO and TDR were visited and searched
for reports or publications [30-32].
Selection of studies
A primary selection, based on title and abstract (com-
piled in reference manager [33]), was performed inde-
pendently by two authors (JK and EO). Duplicate
studies and studies that were not using diagnostic
tests for malaria in pregnant women were removed.
All studies considered relevant by at least one of the
two authors were selected. If the full paper could not
be retrieved online or through the central catalogue of
Dutch academic libraries (NCC), and if the contact
details could be retrieved, the authors were
approached. In case the full paper was obtained, the
same two authors independently assessed the study
for inclusion, based on eligibility (described earlier)
and the availability of data to derive 2 × 2 tables. Dis-
agreements were resolved by discussion or by consult-
ing a third author (PM or ML). Study information and
fulfilment to the inclusion criteria was collected using
an Epidata entry form [34]. If data for RDT evalua-
tions were only partially reported, authors were con-
tacted to provide the data if the contact details were
available.
Data extraction and management
Two authors (JK and EO) collected the data from
included studies independently on forms prepared in
separate Access databases (Microsoft 2003). Information
about the study (title, authors, journal, etc.), study popu-
lation and study design was collected, as well as descrip-
tions of reference and index tests and data for 2 × 2
tables. The database was accompanied by a background
document that explained how each item in the database
should be interpreted and entered. After entry of all stu-
dies, the two databases were compared, and disagree-
ments were resolved by discussion between the two
data-collectors or if necessary with a third author (PM).
Most disagreements in the two data sets turned out to
be data entry errors.
Methodological quality was assessed using the QUA-
D A St o o l[ 3 5 ] .As t u d yw a sc o n s i d e r e dt oh a v eah i g h
risk of partial verification bias if more than 10% of the
patients who received the index test did not receive veri-
fication of their true disease state, and the selection of
patients to receive the reference standard was not ran-
dom. A study was considered to have a high risk of dif-
ferential verification bias if more than 10% of patients
received verification with a different reference standard.
Studies with a high risk of partial or differential verifica-
tion bias were not included in the meta-analysis. A few
additional items were added to the QUADAS tool that
can be important for RDT accuracy. These items are:
‘Has care been taken to store the tests at recommended
circumstances (time, temperature, humidity)?’ and ‘Was
the staff that executed the reference standard trained to
use this test?’. In several studies more than two tests
were compared, and multiple 2 × 2 tables could be
extracted. Several quality items were considered for the
separate test comparisons within one study.
Statistical analysis and data synthesis
For each 2 × 2 table, the estimates of sensitivity and
specificity and their 95% confidence interval were
plotted in forest plots and receiver operating character-
istic (ROC) space in Review Manager [36]. For the
meta-analysis, metandi was used in Stata [37,38]. To
perform metandi, a minimum of four 2 × 2 tables is
required.
Investigation of sources of heterogeneity
Diagnostic accuracy studies are expected to show con-
siderable heterogeneity and the models used are by
default random effects models, taking into account the
between study variation as well as chance variation [39].
To further investigate the sources of heterogeneity, sub-
group analyses was performed rather than including
covariates in the meta-regression models, because
metandi is not capable of including covariates in the
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lase or in combination) detected by the RDT was inves-
tigated as a source of heterogeneity. For other supposed
sources that might affect the accuracy of the RDTs,
such as malaria species, gravidity, anti-malarial treat-
ment and RDT brand, insufficient data was reported to
determine if these issues affected accuracy.
Results
Results of the search
The searches in MEDLINE, EMBASE and Web of
Science (WOS) retrieved 3,069, 3,167 and 2,249 studies,
respectively. After removing duplicates, 169 studies were
selected based on title and abstract. Additional searches
retrieved another 23 studies. From these 192 studies,
131 were excluded for several reasons: full text paper
could not be retrieved (n = 12), no pregnant women
described (n = 18), insufficient data collected or pro-
vided for 2 × 2 tables (n = 54), narrative reviews or edi-
torial or letter (n = 16), description of the same
population as another study (n = 13), no formal evalua-
tion against an eligible reference standard (n = 14) and
various other reasons (n = 4) (Figure 1).
Additional file 1 lists the characteristics of the 61
included studies in the review [7,26,27,29,40-94]. Studies
were performed between 1914 and 2009, and included
approximately 45,000 women during pregnancy or at
delivery. Most studies were conducted in sub-Saharan
Africa (n = 52). Only four were conducted in South-East
Asia (three in India, one in Thailand), and two in
Yemen and one each in, Colombia, Panama and Papua
New Guinea. Corresponding with the geographical loca-
tions, the majority of studies described P. falciparum
i n f e c t i o n s( 5 3o f6 1r e p o r t e dP. falciparum infection; in
eight studies species were not specified). Only six stu-
dies reported P. vivax infections. P. malariae (n = 16)
and P. ovale (n = 6) infections are rarely seen in the pla-
centa, and were more often reported in peripheral blood
as a mixed infection with P. falciparum and only in a
small portion of patients (Additional file 1). There are
not enough studies to perform subgroup analysis for the
different species to determine if there is a difference in
test accuracy to detect different malaria species, and
most importantly between P. vivax and P. falciparum.
Only 13 of 61 studies used placental histology.
Methodological quality of included studies
The results of the quality assessment are presented in Fig-
ure 2. Most studies included a representative patient spec-
trum, but in two studies they included either only patients
that were positive in a reference test or those that were
negative [52,59]. Additionally, one study included patients
that were positive in the index test and 30 negatives, but
not randomly chosen [70]. Selection criteria were not
sufficiently described in 16 studies [27,28,40,43,45-47,55,
62,68,69,72,76,80,81,87]. Very little was reported on sto-
rage conditions of the tests and whether or not staff was
trained for the reference or index tests. In about a quarter
of the studies (n = 15) withdrawals were not explained
[27,42,48,49,51,53,56,61,62,64,69,73,74,80,84].
Partial verification was a problem in four test compar-
isons (in four different studies), and these studies were
removed from the meta-analysis [61,67,80,83]. Differen-
tial verification was not a problem in any of the compar-
isons. For most of the tests (n = 83) the execution of the
test was described sufficiently, but in only a few com-
parisons (n = 17 for index test; n = 30 for the reference
test) did the authors clearly mention that the interpreta-
tion of the tests was blinded, and only in a small num-
ber (n = 30) of the studies they reported that the
reproducibility of the index test was tested.
Findings
Of the 61 studies included in the review, only 49 could be
evaluated in the meta-analyses. These 49 studies are pre-
sented in the forest plots (Figures 3, 4, 5, 6 and 7). Some
Assessment of 
full text
(n= 192)
Included in 
review
(n=61)
8316 discarded, because did not describe 
diagnosis of placental malaria, or were 
narrative reviews or duplicates. 
121 excluded or could not be included, 
because:
-The studied population was not pregnant  
women (n=18)
-No formal evaluation against an eligible 
reference standard (n= 14)
-Narrative review or letter (n= 16)
-Same population is described as another 
included study (n=8)
-Insufficient data collected or provided for 
2x2 tables (n=53)
-Only abstract was available and 2x2 could 
not be extracted (n=12)
Titles and 
abstracts 
(n= 8508 )
Data extraction
(n=71)
10 studies excluded from review because,
- study describes same population as 
another included study (n= 5)
- there is not enough data for 2x2 tables
(n=1)
- case report (n=1)
- case control (n=2)
- described blood from fetal side of placenta
(n=1)
Included in 
meta-
analysis
(n=49)
Figure 1 Flow diagram of selection procedure.
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enough studies to perform meta-analysis of these particu-
lar test comparisons were described and these studies are
listed in Additional file 2 with the retrieved sensitivity and
specificity. A substantial number of studies had to be
excluded from final analyses, because there was not
enough data to fill the 2 × 2 tables (n = 4) or because they
suffered from partial verification bias (n = 2), or the 2 × 2
tables were only available for a subset of the patients (n =
3). In separate cases the studies were excluded, because
0% 25% 50% 75% 100%
Representative spectrum?
Selection criteria described?
Acceptable reference standard?
Execution of reference test described?
Uninterpretable results reported?
Withdrawals explained?
Storage at recommended circumstances?
Staff trained for reference standard?
General Items (n=61)
Yes (high quality) Unclear No (low quality)
0% 25% 50% 75% 100%
Acceptable delay between tests?
Partial verification avoided?
Differential verification avoided?
Incorporation avoided?
Execution of index test described?
Index test results blinded?
Reference standard results blinded?
Clinical data available?
Reproducibility tested?
Staff trained for index test?
Index & comparator test items (n=108)
Yes (high quality) Unclear No (low quality)
Figure 2 Methodological quality assessment of all 61 included studies. Top: general QUADAS items, scored for each study; Bottom: Items
assessed separately for each index and comparator tests (n = 108) within the studies. Data presented as stacked bars representing the
percentage of studies scored as ‘yes’ (green), ‘unclear’ (yellow) or ‘no’ (red) by the authors on each particular quality item.
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a too long a time delay between the tests (n = 1), or they
used only matched negative cases (n = 1). The exact rea-
sons for exclusion of each study are explained in the sec-
tions below. Only the most correctly-conducted studies
were used to determine the accuracy and, therefore, the
studies described above were excluded. The effect of
exclusion of these studies was systematically examined,
and in most cases the summary estimates were essentially
unchanged. When the summary estimates were different
when these tests were included in the analysis, this is dis-
cussed in the sections below.
The median prevalence of malaria (mostly P. falci-
parum) found by placental histology was 33.2% (range
17.2-52.5%). This median prevalence was retrieved from
all included studies using histology and these studies
were published between 1993 and 2009. These studies
all included regular pregnant women presenting for
delivery or recruited at ANC and followed till delivery
[7,26,28,42,51,55,67,69,73,86].
Peripheral and placental blood microscopy vs reference
standard histology
In order to determine whether tests other than placental
histology can be used as substitute reference standards,
the accuracies of microscopy of placental and peripheral
blood were evaluated. Seven studies evaluated micro-
scopy of placental blood with placental histology as
reference test, but one was excluded from the meta-ana-
lysis because there was a high risk of partial verification
bias (Figure 3) [61,70]. Another study was excluded
from the meta-analysis because it included women that
were RDT positive and matched negative women [70].
The summary estimates of the five included studies in
the meta-analysis for sensitivity and specificity were 54%
[40-67 CI] and 97% [95-98 CI], respectively (Table 1
and Figure 8). Since the pathology of P. vivax infections
during pregnancy has not been fully elucidated, the sen-
sitivity and specificity of placental tests might be differ-
ent for P. vivax infections compared to P. falciparum.I f
the study with P. vivax infections was excluded from the
meta-analysis, there was a slight increase in sensitivity
(60% [50-69 CI]) [7].
From the ten studies that evaluated peripheral blood
microscopy against placental histology, two were
excluded from the meta-analysis. One study did not
report false- and true negatives [42], and one study
included women that were RDT positive and matched
negative women [70] (Figure 3). The summary estimates
for sensitivity and specificity of the included studies
*
*
*
*
Figure 3 Forest plots of sensitivity and specificity of microscopy of peripheral and placental blood with placental histology as
reference test. The squares represent the calculated specificity and sensitivity of one test within a study; the black line is the 95% confidence
interval. Tests with a * in front were excluded from the meta-analysis, because of high risk of bias or complete data was not available.
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(Table 1). If the case-control study was included, the
summary sensitivity would have been 49% [35-64 CI].
When performing the meta-analysis with P. falciparum
studies only (P. vivax study [7] removed) the sensitivity
and specificity hardly changed (45% [34-56 CI] and 91%
[84-95 CI] respectively).
In Figure 8 the summary ROC curve presents the
summary estimates for placental blood and peripheral
blood microscopy compared to histology. Placental
blood microscopy had a slightly higher sensitivity and
specificity than peripheral microscopy (Figure 8). There
is, however, quite some overlap in the 95% confidence
regions of the summary estimates, meaning that the
true accuracy of the tests might be more alike (Figure
8). Both tests showed much variation in their sensitivity,
ranging from 23% to 71% for placental blood and from
21% to 62% for peripheral blood, respectively. Neither of
the two tests, however, reaches a summary sensitivity of
at least 90%, and for peripheral blood microscopy the
upper limit of the confidence interval is much lower
than 90% specificity.
Peripheral blood microscopy vs reference test placental
blood microscopy
Many studies (n = 30) evaluated peripheral blood micro-
scopy with placental blood microscopy as a reference, but
four studies were excluded from the meta-analysis. Two of
these four studies presented incomplete data for the 2 × 2
table [7,52], another only presented the 2 × 2 table for a
subset of the patients (those with newborns with malaria)
[48] and in the last study the delay between the sampling
for the two tests is too long [29] (Figure 4). Sensitivity and
specificity from the included studies are plotted in a sum-
mary ROC plot for peripheral blood microscopy with pla-
cental blood microscopy as reference test (Figure 9). The
sensitivity varied from 19% to 100% with a summary esti-
mate of 72% [62-80% CI] (Table 1 and Figure 9). The
*
*
*
*
Figure 4 Forest plots of sensitivity and specificity of peripheral blood microscopy with placental blood microscopy as reference test.
The squares represent the calculated specificity and sensitivity of one test within a study; the black line is the 95% confidence interval. Tests
with a * in front were excluded from the meta-analysis, because of high risk of bias or complete data was not available.
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estimate was 98% [95-99% CI] (Table 1 and Figure 9).
There is one study where a P. vivax infection is observed
in peripheral blood and not in placental blood, but the
summary estimates are not different if this study is
excluded from meta-analysis (sensitivity 73% [63-81 CI]
and specificity 98% [95-99 CI]) [47].
RDT and PCR vs reference test histology
The preferred reference standard for placental malaria
remains histology, but unfortunately, only one study was
included evaluating an RDT (HRP2-Aldolase) with per-
ipheral blood against histology (sensitivity 57% [41-73
CI] and specificity 90% [80-96 CI]) [27]. One other
study evaluated an RDT with placental blood to
*
**
***
**
**
*
*
Figure 5 Forest plots of sensitivity and specificity of RDTs with microscopy of placental blood as reference test. The squares represent
the calculated specificity and sensitivity of one test within a study; the black line is the 95% confidence interval. Tests with a * in front were
excluded from the meta-analysis, because of high risk of bias or complete data was not available; with ** means that a pLDH-based RDT has
been used; *** means that a HRP2-Aldolase-based RDT has been used.
*
*
*
Figure 6 Forest plots of sensitivity and specificity of PCR with microscopy of placental blood as reference test. The squares represent
the calculated specificity and sensitivity of one test within a study; the black line is the 95% confidence interval. Tests with a * in front were
excluded from the meta-analysis, because of high risk of bias or complete data was not available.
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Page 9 of 18histology (sensitivity 100% [92-100 CI] and specificity
56% [41-69 CI]) [70]. No studies evaluated PCR against
histology. Too few studies were collected for meta-ana-
lysis and therefore summary sensitivities and specificities
of RDT and PCR and microscopy could not be
compared.
RDT and PCR vs reference test placental blood
microscopy
As an alternative, some studies used microscopy of pla-
cental blood as a reference standard. Five studies com-
pared RDT with peripheral blood to placental blood
microscopy, and eight compared RDT with placental
blood (Figure 5). Two studies were case-control studies,
and were excluded from the meta-analysis [58,70]. One
other study had incomplete 2 × 2 tables and the two 2
× 2 tables from this study were therefore excluded from
the analysis [52]. This leaves two pLDH tests, one
HRP2-Aldolase and six HRP2 tests with sensitivities
varying from 78% to 95% for peripheral blood and 20%
to 95% for placental blood. Not enough studies were
available to pool the 2 × 2 tables RDTs of peripheral
blood separately, but when RDTs of both peripheral as
placental blood are pooled together, the summary sensi-
tivity is 81% [62-92 CI] and summary specificity is 94%
[76-99 CI] (Table 1 and Figure 9). If RDT of placental
blood is pooled separately, similar sensitivity and specifi-
city are found (Table 1).
Similarly, the 2 × 2 tables of PCR of peripheral and
placental blood compared to placental blood microscopy
can be pooled and analysed together. The 2 × 2 tables
of two studies are not complete; therefore they were not
included in the meta-analysis (Figure 6)[52,59]. Sum-
mary sensitivity (86% [65-95 CI]) is similar to RDT, but
summary specificity (77% [71-82 CI]) is lower (Table 1
and Figure 9).
Compared to peripheral microscopy, RDTs and PCR
have better sensitivity than when compared to placental
blood microscopy as reference standard (Figure 9).
RDTs and PCR, however, do have lower specificity, but
***
**
**
*
*
*
*
*
*
Figure 7 Forest plots of sensitivity and specificity of RDTs and PCR with microscopy of peripheral blood as reference test. The squares
represent the calculated specificity and sensitivity of one test within a study; the black line is the 95% confidence interval. Tests with a * in front
were excluded from the meta-analysis, because of high risk of bias or complete data was not available; with ** means that a pLDH-based RDT
has been used; *** means that a HRP2-Aldolase-based RDT has been used.
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Page 10 of 18Table 1 Summary of findings
What is the diagnostic accuracy of microscopy of peripheral and placental blood to correctly identify histologically confirmed placental
malaria (PM)?
Population Pregnant women
Settings At delivery where both placental and peripheral material is available; mostly P. falciparum infections
Index test Microscopic examination of placental or peripheral blood slide
Reference Test Histological examination of placental biopsies
Type of test Effect
[95% CI]
Participants
(studies)
Median
prevalence
(range)
Implications of results Quality and comments
Microscopy of
placental
blood
Sensitivity
54%
[40-67]
Specificity
97%
[95-98]
2153
(5)
24.4%
(18.4-35.5)
With a prevalence of 25%, 25 out of 100
pregnant women will develop PM; 12 and 14
patients will be missed by placental and
peripheral microscopy.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals poorly
Reported.
Microscopy of
peripheral
blood
Sensitivity
44%
[34-54]
Specificity
92%
[86-95]
4044
(8)
28.6%
(17.2-52.5)
With a prevalence of 25%, 6 patients will be
false positive in peripheral microscopy, but
treatment is not harmful and can act as
prophylaxis during the rest of the pregnancy.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals poorly
reported; 1 study did not report selection
criteri; 1 did not report the execution of the
reference test; risk of verification bias in
study.
What is the diagnostic accuracy of RDTs and PCR to correctly identify PM confirmed by microscopy of placental blood?
Population Pregnant women
Settings At delivery where both placental- and peripheral blood is available; mostly P. falciparum infections
Index test RDT or PCR with peripheral or placental blood
Reference Test Microscopic examination of placental blood slide
Type of test/
subgroups
Effect
[95% CI]
Participants
(studies)
Median
prevalence
(range)
Implications of results Quality and comments
Microscopy of
peripheral
blood
Sensitivity
72%
[62-80]
Specificity
98%
[95-99]
16609
(26)
15.9%
(3.3-74.0)
Of 16 of 100 patients positive in placental
blood, 4 would be missed in peripheral blood
by microscopy.
Representative patient spectrum; 4 did not
describe selection criteria; execution of
index/reference test not reported in 13 tests
RDT of placental and peripheral blood
Peripheral and
placental
blood pooled
together
Sensitivity
81%
[62-92]
Specificity
94%
[76-99]
3141
(5)
16.2%
(2.4-11
34.9)
Of 16 of 100 patients positive with placental
blood microscopy, 3 would be missed in any
type RDT. Of 11 of 100 patients positive with
placental blood microscopy, 3 patients would
be missed by RDTs with placental blood. With
a prevalence of 16%, 5 patients will be false
positive with RDTs compared to placental
blood microscopy.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals and
uninterpretable results poorly reported;
execution of test not reported in 3/7 tests; 1
study did not report selection criteria.
only placental
Blood
Sensitivity
76%
[44-92]
Specificity
95%
[87-99]
2124
(4)
11.20%
(2.4 -22.6)
PCR of placental and peripheral blood
all types of
PCR
Sensitivity
86%
[65-95]
Specificity
77%
[71-82]
2608
(6)
18.5%
(1.7-34.9)
Of 18 of 100 patients that test positive in
placental blood microscopy, 3 would be
missed by PCR, but 19 would be false
positive.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals and
uninterpretable results poorly reported.
What is the diagnostic accuracy of RDTs and PCR to correctly identify microscopically confirmed peripheral malaria infection during
pregnancy?
Population Pregnant women
Settings During pregnancy, placental examination not possible; mostly P. falciparum infections
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Page 11 of 18based on the available data, it is not possible to con-
clude if these are indeed false positives, or infections
that are missed by placental blood microscopy yet
detected by RDT or PCR.
RDT and PCR vs reference test peripheral blood
microscopy
Although microscopy of peripheral blood is the least
appropriate reference test for placental malaria as deter-
mined in a previous section, it has often been used as a
reference test in practice. Many studies have been per-
formed during pregnancy and not at delivery, which
explains why peripheral blood microscopy is used. Ten
s t u d i e sc o m p a r e dR D T s( t w op L D Ha n do n eH R P 2 -
Aldolase and seven HRP2-based tests) to microscopy of
peripheral blood and 14 compared PCR to peripheral
microscopy. For both PCR and RDT, three studies each
were excluded from meta-analysis because of incomplete
data [40,52,59], case control [58] or high risk of verifica-
tion bias [80,83] (only for PCR in [80]). Sensitivity and
specificity is presented between quotation marks in the
section below to underline the fact that peripheral blood
microscopy is not an appropriate reference test for pla-
cental malaria.
Analysis was performed for HRP2-based RDTs sepa-
rately (Figure 7). Too few studies were retrieved in
order to perform subgroup analysis on pLDH based
RDTs, and therefore a sensitivity analysis was performed
by comparing all RDT studies with a subgroup of
HRP2-based RDTs. The summary estimate of “sensitiv-
ity” was higher for the HRP2 subgroup (94% [91-96 CI])
compared to the overall analysis for all RDT types (81%
[55-93 CI]). For the summary estimate of the “specifi-
city”, however, the opposite was observed: 81% [71-88
CI] for the HRP2 subgroup and 94% [82-98 CI] for all
type RDTs (Table 1 and Figure 10). Although the differ-
ence is not significant, it might indicate that, at least for
placental malaria, there is a difference in accuracy
between the different RDT types (Figure 10).
In studies where PCR was compared to microscopy of
peripheral blood, a quite good “sensitivity” was found
(71% - 100%) except for one outlier (42%), but a low
“specificity” was observed, varying from 54% to 97%
(Figure 7). This resulted in the summary estimates of
“sensitivity” and “specificity” of 94% [86-98 CI] and 75%
[63-84 CI] respectively (Table 1 and Figure 10).
Discussion
To estimate the accuracy of RDTs for diagnosing
malaria infection in pregnant women, the results of 49
studies were analysed. Few studies exist that fully evalu-
ate microscopy, RDTs and PCR against the gold stan-
dard, placental histology, and each other. This makes it
difficult to directly compare the accuracies of the differ-
ent tests, and therefore currently no reliable data about
the accuracy of RDTs and PCR for the detection of pla-
cental malaria is available. The present study shows that
microscopy of both placental and peripheral blood do
not detect many placental infections that are identified
by histology (sensitivities of 54% and 44%) and cannot
reliably replace histology as a reference standard for pla-
cental P. falciparum infection. Despite these limitations
Table 1 Summary of findings (Continued)
Index test RDT or PCR with peripheral blood
Reference Test microscopic examination of peripheral blood slide
Type of test/
subgroups
Effect
[95% CI]
Participants
(studies)
Median
prevalence
(range)
Implications of results Quality and comments
RDT of peripheral blood
all types
(pLDH and
HRP2)
Sensitivity
81%
[55-93]
Specificity
94%
[82-98]
5340
(7)
17.60%
(1.3-51.3)
Of 18 of 100 patients positive in peripheral
blood microscopy, 3 would be missed in any
type RDT. Of 28 of 100 patients positive in
peripheral blood microscopy, 2 patients
would be missed in HRP2 RDTs.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals and
uninterpretable results poorly reported; test
execution not reported in 3/7 tests; 1 study
did not report selection criteria.
only HRP2
based
Sensitivity
94%
[91-96]
Specificity
81%
[71-88]
1834(4) 28.10%
(17.6-51.3)
With a prevalence of 28%, 14 patients will be
false positive with HRP2 RDTs compared to
peripheral blood microscopy.
PCR of peripheral blood
all types of
PCR
Sensitivity
94%
[86-84]
5741
(11)
19.0%
(5.3-51.3)
Of 19 of 100 patients that test positive in
peripheral blood microscopy, only 1 would be
missed by PCR, but 20 would be false positive
compared to peripheral blood microscopy.
Representative patient spectrum; uncertain if
all tests blinded; withdrawals and
uninterpretable results poorly reported;
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Page 12 of 18RDTs, especially HRP2-based tests, appear to have rea-
sonable accuracy compared to microscopy. The World
Health Organization (WHO) together with the Founda-
tion for Innovative New Diagnostics (FIND) have per-
formed extensive testing of many RDT devices and
there is a great need to compare the best tests from that
evaluation with histology, microscopy and PCR in preg-
nant women [20].
When using placental microscopy as a reference test,
PCR has the best sensitivity, followed by RDT and both
have higher sensitivity than peripheral microscopy. Per-
ipheral microscopy, however, has the highest specificity,
followed closely by RDT. Based on these results, RDTs
seem a good alternative for diagnosis of placental
malaria. For the determination of the accuracy of RDT
and PCR compared to placental blood microscopy, how-
ever, tests performed on both peripheral and placental
blood were pooled. This might have introduced bias,
since the starting material is not the same, and there-
fore, the accuracy might be different. There were, how-
ever, too few studies performed on peripheral blood
alone to perform meta-analysis. The pooled summary
sensitivities and specificities are not that different from
the summary values of these tests using placental blood,
but this may be due to the fact that these tests are a
large proportion of the pooled analysis.
Compared to the imperfect reference standard periph-
eral microscopy, the proportion of microscopy positives
detected by any RDT ("sensitivity”) was 81% [51-95 CI].
The proportion microscopy negatives, with a negative
RDT ("specificity”), was 94% [76-99 CI]. As the RDTs
seem to miss patients that are positive in microscopy,
this is not very reassuring for the value of RDTs for the
diagnosis of malaria in pregnant women. Nevertheless,
HRP2-based RDTs might have adequate sensitivity (94%
[91-96 CI]).
The results in this study suggest that the proportion
of microscopy positives detected by HRP2-based RDTs
compared to peripheral microscopy is higher than for
pLDH-based RDTs. The proportion microscopy nega-
tives with a negative RDT, however, is lower for HRP2
Figure 8 Summary ROC plot of sensitivity and specificity of
peripheral and placental blood microscopy with placental
histology as a reference test. The sensitivity of a test is plotted
against 1-specificity, allowing comparison of both parameters at the
same time for multiple tests. The rectangles and diamonds
represent individual studies and size of the rectangles/diamonds is
proportional to the number of patients included in the study. The
thick round spots are the summary estimates of sensitivity and
specificity and the dotted ellipses around the spots represent the
95% confidence intervals around the summary estimates. Black:
peripheral blood microscopy; Red: placental blood microscopy. The
reference test used to determine the plotted accuracies in this
figure is placental histology.
Figure 9 Summary ROC plot of sensitivity and specificity of
RDT and PCR of peripheral and placental blood and
microscopy of peripheral blood with placental blood
microscopy as reference test. The sensitivity of a certain test is
plotted against 1-specificity, allowing comparison of both
parameters at the same time for multiple tests. The squares,
diamonds and open circles represent individual studies and size of
the rectangles/diamonds/circles is proportional to the number of
patients included in the study. The thick round spots are the
summary estimates of sensitivity and specificity and the dotted
ellipses around the spots represent the 95% confidence intervals
around the summary estimates. Black (squares): RDTs (detecting
HRP2 or pLDH or HRP2-Aldolase). Red (diamonds): peripheral blood
microscopy. Green (circles): PCR; The reference test used to
determine the plotted accuracies in this figure is placental blood
microscopy.
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Page 13 of 18RDTs compared to pLDH RDTs. This pattern is similar
to the results of a meta-analysis of RDTs for uncompli-
cated malaria, and the sensitivity of HRP2-based RDTs
for pregnant women (94% [91-96 CI]) is very similar to
that for uncomplicated malaria (95% [93-96 CI]) [18].
The specificity compared to peripheral microscopy for
HRP2-based RDTs for pregnant women (81% [71-88
CI]), however, is much lower than for uncomplicated
malaria (95% [93-99 CI]). A possible explanation for this
observation is that peripheral microscopy is not a suita-
ble reference test for placental malaria and does not
detect all placental infections, whereas the HRP2 RDTs
might be able to detect these infections, resulting in a
lower specificity when compared to peripheral micro-
scopy. This is strengthened by the specificity of HRP2
RDTs (90% [84-95 CI]) compared to placental blood
microscopy, which detects more placental infections
than peripheral microscopy. Direct comparisons of
HRP2 RDTs with histology are needed to confirm this.
For PCR, the proportion of microscopy positives
detected ("sensitivity”) was 98% [91-99 CI] and the pro-
portion microscopy negatives, with a negative PCR
("specificity”), was 65% [59-72 CI]. PCR may seem to
miss fewer patients with peripheral P. falciparum para-
s i t e st h a na nR D T ,b u td o e si n d i c a t ean u m b e ro f
women without parasites detected by microscopy as
having malaria. Whether these are cases that were
missed by microscopy or whether these were false posi-
tive PCR results, resulting in low specificity, needs to be
further investigated.
The sensitivity and specificity of tests vary with para-
site density, and many included studies report lower
sensitivities at lower parasite densities (two studies for
PCR and RDT; seven for RDTs; four for microscopy).
This factor is a particular challenge for malaria infec-
tions during pregnancy in both high and low transmis-
sion settings, especially for multigravid women who are
often reported to have lower parasite densities. Of the
included studies, 13 report higher parasite densities in
peripheral and/or placental blood for primi- and/or
secundigravidae. In high transmission areas, women
have acquired immunity during their life, and although
they might have substantial placental sequestration
(especially in primi- and secundigravidae), they can have
a lower amount of parasites in the circulation by clear-
ance of infected red blood cells by the immune system.
In low transmission areas, women have low or no
immunity and women can get sick at initially low para-
site densities. Therefore it is very important for the
diagnosis of malaria in pregnant women that the test
has sufficient accuracy at lower parasite densities, and
low parasite density might partially explain the poor
performance of pLDH RDTs.
In a previous report, prevalence of placental malaria
estimated by different tests was compared within each
study [11]. However, even if the prevalence detected by
one test is higher than the prevalence detected with the
other test, it does not necessarily mean that the same
cases are detected. Additionally, in this way it is not
clear whether the positives found by each test are true
positives or false positives. Nevertheless, the conclusions
of that report and this review are broadly similar. His-
tology found a higher prevalence than placental blood
microscopy and placental blood microscopy in turn
found a higher prevalence than peripheral microscopy in
four out of six studies. In both peripheral and placental
blood, in nearly all studies, higher prevalence was found
using PCR than using RDT and higher prevalence was
found using RDT than using microscopy. No studies
compared prevalence estimated by RDT and PCR to
prevalence found by histology.
Figure 10 Summary ROC plot of sensitivity and specificity of
RDT and PCR with peripheral blood with peripheral blood
microscopy as reference test. The sensitivity of a certain test is
plotted against 1-specificity, allowing comparison of both
parameters at the same time for multiple tests. The rectangles,
diamonds and circles represent individual studies and size of the
rectangles/diamonds/circles is proportional to the number of
patients included in the study. The thick round spots are the
summary estimates of sensitivity and specificity for the different test
types and the dotted ellipses around the spots represent the 95%
confidence intervals around the summary estimates. Black
(rectangles): PCR studies; Red (diamonds): studies with HRP2 based
RDTs only; Green (circles): studies with RDTs, including both HRP2,
pLDH and HRP2-Aldolase detecting tests. The reference test used to
determine the plotted accuracies in this figure is placental histology.
The inclusion of the pLDH and Aldolase-HRP2 based RDTs
dramatically changes the summary estimate and confidence interval
(green) compared to HRP2 tests alone (red), the sensitivity is much
lower with the pLDH tests.
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Page 14 of 18The results presented in this review are mainly applic-
able to sub-Saharan Africa, as 85% of the included stu-
dies were conducted in that area. It is surprising that
only a few studies were available evaluating diagnostics
in the Asian-Pacific region, considering that most preg-
nancies at risk in the world are located in this region
[6]. In line with this observation, most studies described
P. falciparum infections, and only six studies reported P.
vivax infections. Meta-analysis was based on studies of
which the majority described P. falciparum infections
and studies with P. vivax infections had little influence
on the outcome. Therefore, conclusions in this review
are mainly applicable to P. falciparum infections. Due to
the potential pathological differences between P. falci-
parum and P. vivax infection in pregnancy a difference
in diagnostic accuracy of the various tests is expected
between the species and more studies should aim at
evaluating diagnostics in P. vivax-infected pregnant
women in the future. Too few studies with P. vivax
infections were included in the meta-analysis to be able
to determine if there is a difference in accuracy.
The use of PCR for diagnosis of (placental) malaria
remains a matter of discussion, especially in the submi-
croscopic cases, because it is difficult to determine what
the PCR is detecting. It is very sensitive in detecting
parasite nucleic acids, but it is unclear if this is a resi-
dual from a non-viable sequestered parasite, or a viable
parasite or gametocyte. Additionally, there is some dis-
cussion whether these low parasite levels detected by
PCR are clinically relevant. Several studies have tried to
address this issue by researching the association of a
positive (submicroscopic) PCR result and outcome mea-
sures such as anaemia, low birth weight and premature
delivery. A systematic review has been conducted to
summarize this data and concluded that the frequency
of anaemia is significantly lower in uninfected women
compared to women with a submicroscopic infection,
although the risk is lower than with microscopic infec-
tions, and a similar pattern is found for low birth weight
[95]. The review on the effects of submicroscopic infec-
tions did not include three studies that have been
described in the current study [60,90,93]. One of these
three studies described a significantly increased risk of
anaemia with submicroscopic infections compared to
PCR- and microscopy negative women, as well [60].
One of the other studies describes that submicroscopic
infection was predictive of low birth weight in HIV posi-
tive, but not HIV negative women [90]. More compari-
sons with histology might shed more light on this issue
and show that a significant proportion of the peripheral
submicroscopic infections, are in fact placental infec-
tions. As mentioned before, pregnant women often have
low parasite densities, and tests should have good sensi-
tivity at these low densities; PCR techniques often have
better sensitivities at low parasite densities than RDTs
and microscopy.
Conclusions
Currently, there is no reliable data about the accuracy of
RDTs and PCR for the detection of placental malaria.
This is because the studies done so far used invalid
reference standards. Before a firm conclusion can be
drawn about whether RDTs or PCR can be used to
detect placental malaria, these tests should be evaluated
against histological examination of the placenta. Direct
comparisons of RDTs and PCR against histology versus
peripheral microscopy against histology are needed to
decide whether RDTs or PCR have better accuracy for
placental malaria than (currently used) peripheral
microscopy.
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